Edetic Acid

Edetic Acid

SCHEMBL285310

O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O.[CaH2].[CaH2]

nearest known ligand 0.93

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.93
EYA2 O00167 1/20 0.93
APP P05067 1/20 0.93
ACE P12821 1/20 0.93
BLM P54132 2/20 0.88
PMP22 Q01453 2/20 0.88
TSHR P16473 2/20 0.88
KDM4E B2RXH2 2/20 0.88
ALOX15 P16050 2/20 0.88
LMNA P02545 1/20 0.88
CHRM2 P08172 1/20 0.88
ADRA2A P08913 1/20 0.88
DRD1 P21728 1/20 0.88
SLC6A2 P23975 1/20 0.88
SLC6A4 P31645 1/20 0.88
CYP2C19 P33261 1/20 0.88
ADRA1A P35348 1/20 0.88
DRD3 P35462 1/20 0.88
SLC6A3 Q01959 1/20 0.88
HRH3 Q9Y5N1 1/20 0.88

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Edetic Acid SCHEMBL4367077 1.00 TDP1 (0.93) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL4367072 1.00 TDP1 (0.93) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL42055 1.00 TDP1 (0.93) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL4533309 0.97 TDP1 (0.88) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL3957470 0.97 TDP1 (0.88) TDP1EYA2APPACEBLM
Pentetic Acid SCHEMBL9130818 0.97 TDP1 (0.94) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL769944 0.97 TDP1 (0.88) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL1535271 0.97 TDP1 (0.88) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL531146 0.97 TDP1 (0.88) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL121502 0.97 TDP1 (0.88) TDP1EYA2APPACEBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119405892-B Medical magnesium alloy composite coating for promoting bone growth, preparation method thereof and medical magnesium alloy 华融科创生物科技(天津)有限公司 2025-05-02 CN claimed
US-20240165275-A1 STABLE FORMULATIONS OF INDOCYANINE GREEN PROVEPHARM LIFE SOLUTIONS (FR) 2024-05-23 US claimed
EP-4308081-A2 STABLE FORMULATIONS OF INDOCYANINE GREEN Provepharm Life Solutions (FR) 2024-01-24 EP claimed
WO-2023222108-A1 METHOD FOR PREPARING ANTIBODY-DRUG CONJUGATE 上海迈晋生物医药科技有限公司 2023-11-23 WO claimed
CN-116997325-A Stable indocyanine green formulations 普如制药生命解决方案公司 2023-11-03 CN claimed
CN-116919857-A Whitening, tightening and anti-wrinkle supermolecule grape seed oil composition and preparation method thereof 哈尔滨敷尔佳科技股份有限公司 2023-10-24 CN claimed
CN-114668762-A A pharmaceutical composition 江苏恒瑞医药股份有限公司 2022-06-28 CN claimed
US-20170189392-A1 LIPOSOME OF IRINOTECAN OR IRINOTECAN HYDROCHLORIDE AND PREPARATION METHOD THEREOF SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. (CN) 2017-07-06 US claimed
EP-2508170-B1 LIPOSOME OF IRINOTECAN OR ITS HYDROCHLORIDE AND PREPARATION METHOD THEREOF JIANGSU HENGRUI MEDICINE CO (CN) 2015-07-29 EP claimed
US-20120282325-A1 LIPOSOME OF IRINOTECAN OR ITS HYDROCHLORIDE AND PREPARATION METHOD THEREOF SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. (CN) 2012-11-08 US claimed
EP-2508170-A1 LIPOSOME OF IRINOTECAN OR ITS HYDROCHLORIDE AND PREPARATION METHOD THEREOF Jiangsu Hengrui Medicine Co., Ltd. (CN) 2012-10-10 EP claimed
US-20120177699-A1 Preparation Method of Drug Loaded Emulsion SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. (CN) 2012-07-12 US claimed
EP-2428203-A1 A NANO-EMULSION INJECTION OF VINCA ALKALOIDS AND THE PREPARATION METHOD THEREOF Jiangsu Hengrui Medicine Co., Ltd. (CN) 2012-03-14 EP claimed
US-20120045489-A1 Nano-Emulsion Injection of Vinca Alkaloids and the Preparation Method Thereof SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. (CN) 2012-02-23 US claimed
CN-1709239-A Gingko lactone lyophilized powder for injection and its preparing method WUZHONG SUYAO MEDICINE DEV LLC (CN) 2005-12-21 CN claimed
CN-119405892-B Medical magnesium alloy composite coating for promoting bone growth, preparation method thereof and medical magnesium alloy 华融科创生物科技(天津)有限公司 2025-05-02 CN disclosed
US-20240165275-A1 STABLE FORMULATIONS OF INDOCYANINE GREEN PROVEPHARM LIFE SOLUTIONS (FR) 2024-05-23 US disclosed
EP-0695138-A1 STABILIZATION OF VOLTAGE SENSITIVE DYES MALLINCKRODT MEDICAL, INC. (US) 1996-02-07 EP disclosed
EP-0497782-B1 STABLE, FLUID, AQUEOUS PIGMENT DISPERSIONS UNIVERSAL FOODS CORP (US) 1995-12-20 EP disclosed
WO-1994023646-A1 STABILIZATION OF VOLTAGE SENSITIVE DYES MALLINCKRODT MEDICAL, INC. (US) 1994-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240165275-A1 STABLE FORMULATIONS OF INDOCYANINE GREEN SLC7A1, IK, SLC10A2 TDP1 3226/4885EYA2 321/4885APP 1653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.